Recent Updates
Recently added Catalysts
CYH

CYH Announces First Quarter 2020 Results

Key Takeaway: Investor Contact: Kevin Hammons Executive Vice President and Chief Financial Officer (615) 465-7000 COMMUNITY HEALTH SYSTEMS, INC. ANNOUNCES FIRST QUARTER 2020 RESULTS FRANKLIN, Tenn. (April 28, 2020) Community Health Systems, Inc. (NYSE: CYH) (the Company ) today annou

Full Press Release Details

Investor Contact: Kevin Hammons
Executive Vice President
and Chief Financial Officer
(615) 465-7000
COMMUNITY HEALTH SYSTEMS, INC. ANNOUNCES
FIRST QUARTER 2020 RESULTS
FRANKLIN, Tenn. (April 28, 2020) Community Health Systems, Inc. (NYSE: CYH) (the Company ) today announced
financial and operating results for the three months ended March 31, 2020.
The following highlights the financial and operating
results for the three months ended March 31, 2020.
Net operating revenues for the three months ended March 31, 2020, totaled $3.025 billion, a 10.4 percent decrease,
compared with $3.376 billion for the same period in 2019.
Net income attributable to Community Health Systems, Inc. common
stockholders was $18 million, or $0.15 per share (diluted), for the three months ended March 31, 2020, compared with net loss of $(118) million, or $(1.04) per share (diluted), for the same period in 2019. Excluding the adjusting items as
presented in the table in footnote (e) on page 13, net loss attributable to Community Health Systems, Inc. common stockholders was $(1.59) per share (diluted), for the three months ended March 31, 2020, compared to $(0.53) per share
(diluted) for the same period in 2019. The change in tax valuation allowance (which was one of the adjusting items referenced above) had a positive impact of $240 million, or $2.10 per share (diluted), on net income attributable to Community
Health Systems, Inc. common stockholders, and arose from the discrete tax benefits related to the release of federal and state valuation allowances on IRC Section 163(j) interest carryforwards as a result of an increase to the deductible
interest expense allowed for 2019 and 2020 under the Coronavirus Aid, Relief and Economic Security Act (the CARES Act ) that was enacted during the three months ended March 31, 2020. Weighted-average shares outstanding (diluted) were
114 million for the three months ended March 31, 2020, and 113 million for the three months ended March 31, 2019.
Adjusted EBITDA for the three months ended March 31, 2020, was $309 million compared with $391 million for the same period in
2019, representing a 21.0 percent decrease.
CYH Announces First Quarter 2020 Results
The consolidated operating results for the three months ended March 31, 2020, reflect a
13.3 percent decrease in admissions and a 12.8 percent decrease in adjusted admissions, compared with the same period in 2019. On a same-store basis, admissions decreased 5.2 percent and adjusted admissions decreased 4.8 percent
for the three months ended March 31, 2020, compared with the same period in 2019. On a same-store basis, net operating revenues decreased 3.5 percent for the three months ended March 31, 2020, compared with the same period in 2019.
Commenting on the results, Wayne T. Smith, chairman and chief executive officer of Community Health Systems, Inc., said, We are all
grateful for the courage and commitment of our nation s healthcare workers as they put the care of their patients above all else in confronting COVID-19. Across our hospitals, physicians, nurses, and everyone else on the front lines have
helped to save lives. Our organization has leveraged its resources to provide a rapid, coordinated and effective response to the pandemic. Now, we are also focused on reopening services where we can, especially for patients who have deferred
important surgeries, procedures and other appointments. As we continue to manage our operations through the COVID-19 pandemic, our organization is doing everything possible to limit the spread of COVID-19 and to ensure our communities continue to
have access to safe, quality healthcare.
Due to the decline in patient volumes as a result of the COVID-19 pandemic beginning during the second
half of March, the impact from the COVID-19 pandemic on the Company s operations and financial results for the three months ended March 31, 2020 included decreases in net operating revenues and
increases in expenses related to supply chain and other expenditures.
As previously announced in a Current Report on Form 8-K filed by the Company on April 6, 2020 (the April 6 Form 8-K ), the Company is not able to fully quantify the impact that COVID-19 will have on its financial results during 2020, but expects developments related to COVID-19 to materially affect the Company s financial performance in 2020.
Moreover, as a result of the continuously changing and unpredictable environment related to COVID-19, as disclosed in the April 6 Form 8-K, the Company withdrew its
2020 financial guidance previously issued in its earnings release dated February 19, 2020 and is not providing further guidance in this earnings release.
Federal and state governments have passed legislation, promulgated regulations, and taken other administrative actions intended to assist
healthcare providers in providing care to COVID-19 and other patients during the public health emergency. Sources of relief include the CARES Act, which was enacted on March 27, 2020, and the Paycheck
Protection Program and Health Care Enhancement Act (the PPPHCE Act ), which was enacted on April 24, 2020. The CARES Act includes $100 billion in funding to be distributed to eligible providers through the Public Health and
Social Services Emergency Fund (the PHSSEF ) as well as an expansion of the Medicare Accelerated and Advance Payment Program. The PPPHCE Act includes additional emergency appropriations for COVID-19
response, including $75 billion to be distributed to eligible providers through the PHSSEF.
In April 2020, the Company received
approximately $245 million in payments through the PHSSEF and received accelerated Medicare payments of approximately $1.2 billion via the Medicare Accelerated and Advance Payment Program. These payments did not qualify for recognition in
the three months ended March 31, 2020. PHSSEF payments (both under the CARES Act and the PPPHCE Act) are intended to compensate healthcare providers for lost revenues and incremental expenses incurred in response to the COVID-19 pandemic and are not required to be repaid provided that recipients attest to and comply with certain terms and conditions, including (in the case of payments under the CARES Act) limitations on balance
billing and not using funds received from the PHSSEF to reimburse expenses or losses that other sources are obligated to reimburse (terms and conditions with respect to payments under the PPPHCE Act have not been finalized). In contrast, the
payments under the Medicare Accelerated and Advance Payment Program are advances that providers must repay. The accelerated Medicare payments are interest free for up to 12 months and the program currently requires that CMS recoup the accelerated
payments beginning 120 days after receipt by the provider, by withholding future Medicare fee-for-service payments for claims until such time as the full accelerated
payment has been recouped. The program currently requires that any outstanding balance remaining after 12 months must be repaid by the provider or be subjected to a 10.25% interest rate.
CYH Announces First Quarter 2020 Results
The PHSSEF payments and accelerated payments received to date and which the Company may
receive in the future under the CARES Act and the PPPHCE Act as noted above, or other legislation, will be beneficial in addressing the impact of the COVID-19 pandemic on its results of operations and
financial position. However, the Company is unable to assess the extent to which anticipated negative impacts on the Company arising from the COVID-19 pandemic will be offset by amounts and benefits received,
and which the Company may receive in the future, under the CARES Act, the PPPHCE Act or other legislation.
On January 1, 2020, the
Company completed the divestiture of three hospitals (in respect of which the Company received proceeds at a preliminary closing on December 31, 2019). In addition, since January 1, 2020 the Company has entered into several definitive
agreements to sell a total of seven hospitals, for which the Company expects to receive aggregate proceeds of approximately $400 million. These divestitures, which are expected to be completed at various times during the second and third quarters of
2020, will mark the end of the formal portfolio rationalization strategy, which commenced in 2017. There can be no assurance that these potential divestitures subject to definitive agreements will be completed, or if they are completed, the ultimate
timing of the completion of these divestitures. The Company continues to receive interest from potential acquirers for certain of its hospitals, and may, from time to time, consider selling additional hospitals following the completion of the
Company s formal portfolio rationalization strategy.
Financial and statistical data for 2019 and 2020 presented in this press
release includes the operating results of divested hospitals through the effective closing date of each respective divestiture. Same-store operating results exclude the results of a hospital acquired in 2019 and the hospitals divested in 2019 and
Information About Non-GAAP Financial Measures
This earnings release presents Adjusted EBITDA, a non-GAAP financial measure, which is EBITDA adjusted
to add back net income attributable to noncontrolling interests and to exclude loss (gain) from early extinguishment of debt, impairment and loss on sale of businesses, expense related to government and other legal settlements and related costs,
expense related to employee termination benefits and other restructuring charges, expense from settlement and fair value adjustments on the CVR agreement liability related to the Health Management Associates, Inc. ( HMA ) legal proceedings
and related legal expenses, the impact of changes in estimate to increase the professional liability claims accrual recorded during the second quarter of 2019 (which estimate was further revised in the third quarter of 2019 based on updated
actuarial analysis) with respect to claims incurred in 2016 and prior years and expense related to the valuation allowance recorded in the second quarter of 2019 to reserve the outstanding balance of a promissory note received from the buyer in
connection with the sale of two of the Company s hospitals in 2017, as well as income from a reduction of the valuation allowance on the outstanding balance of a promissory note from the buyer of another hospital. For information regarding why
the Company believes Adjusted EBITDA provides useful information to investors, and for a reconciliation of Adjusted EBITDA to net income (loss) attributable to Community Health Systems, Inc. stockholders, see footnote (c) to the Financial
Highlights, Financial Statements and Selected Operating Data below.
Additionally, this earnings release presents adjusted net income
(loss) attributable to Community Health Systems, Inc. common stockholders per share (diluted), a non-GAAP financial measure, to reflect the impact on net income (loss) attributable to Community Health Systems,
Inc. common stockholders per share (diluted) from the selected items used in the calculation of Adjusted EBITDA. For information regarding why the Company believes this non-GAAP financial measure provides
useful information to investors, and for a reconciliation of this non-GAAP financial measure to net income (loss) attributable to Community Health Systems, Inc. common stockholders per share (diluted), see
footnote (e) to the Financial Highlights, Financial Statements and Selected Operating Data below.
Community Health Systems, Inc. is
one of the largest publicly traded hospital companies in the United States and a leading operator of general acute care hospitals in communities across the country. The Company, through its subsidiaries, owns, leases or operates 99 affiliated
hospitals in 17 states with an aggregate of approximately 16,000 licensed beds.
CYH Announces First Quarter 2020 Results
The Company s headquarters are located in Franklin, Tennessee, a suburb south of
Nashville. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol CYH. More information about the Company can be found on its website at www.chs.net.
Community Health Systems, Inc. will hold a conference call on Wednesday, April 29, 2020, at 10:00 a.m. Central, 11:00 a.m. Eastern, to
review financial and operating results for the first quarter ended March 31, 2020. Investors will have the opportunity to listen to a live internet broadcast of the conference call by clicking on the Investor Relations link of the
Company s website at www.chs.net. To listen to the live call, please go to the website at least fifteen minutes early to register, download and install any necessary audio software. For those who cannot listen to the live broadcast, a
replay will be available shortly after the call and will continue to be available for approximately 30 days. Copies of this press release and conference call slide show, as well as the Company s Current Report on Form 8-K (including this press release), will be available on the Company s website at www.chs.net.
CYH Announces First Quarter 2020 Results
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
Financial Highlights (a)(b)
(In millions, except per share amounts)
Three Months Ended March 31,
2020 2019
Net operating revenues $ 3,025 $ 3,376
Net income (loss) (f), (g) 34 (101 )
Net income (loss) attributable to Community Health Systems, Inc. stockholders 18 (118 )
Adjusted EBITDA (c) 309 391
Net cash provided by operating activities 57 133
Earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders:
Basic (f), (g) $ 0.15 $ (1.04 )
Diluted (e), (f), (g) 0.15 (1.04 )
Weighted-average number of shares outstanding (d):
Basic 114 113
Diluted 114 113
footnotes, see pages 11, 12 and 13.
CYH Announces First Quarter 2020 Results
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Income (Loss) (a)(b)
(In millions, except per share amounts)
Three Months Ended March 31,
2020 2019
Amount % of Net Operating Revenues Amount % of Net Operating Revenues
Net operating revenues $ 3,025 100.0 % $ 3,376 100.0 %
Operating costs and expenses:
Salaries and benefits 1,408 46.4 % 1,542 45.7 %
Supplies 498 16.5 % 558 16.5 %
Other operating expenses 737 24.4 % 811 24.1 %
Government and other legal settlements and related costs (g) 2 0.1 % 5 0.1 %
Lease cost and rent 81 2.7 % 80 2.4 %
Depreciation and amortization 144 4.8 % 153 4.5 %
Impairment and loss on sale of businesses, net (f) 45 1.5 % 38 1.1 %
Total operating costs and expenses 2,915 96.4 % 3,187 94.4 %
Income from operations (f), (g) 110 3.6 % 189 5.6 %
Interest expense, net 262 8.7 % 257 7.6 %
Loss from early extinguishment of debt 4 0.1 % 31 0.9 %
Equity in earnings of unconsolidated affiliates (7 ) (0.3 ) % (5 ) (0.1 ) %
Loss before income taxes (149 ) (4.9 ) % (94 ) (2.8 ) %
(Benefit from) provision for income taxes (183 ) (6.0 ) % 7 0.2 %
Net income (loss) (f), (g) 34 1.1 % (101 ) (3.0 ) %
Less: Net income attributable to noncontrolling interests 16 0.5 % 17 0.5 %
Net income (loss) attributable to Community Health Systems, Inc. stockholders $ 18 0.6 % $ (118 ) (3.5 ) %
Earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders:
Basic (f), (g) $ 0.15 $ (1.04 )
Diluted (e), (f), (g) $ 0.15 $ (1.04 )
Weighted-average number of shares outstanding (d):
Basic 114 113
Diluted 114 113
footnotes, see pages 11, 12 and 13.
CYH Announces First Quarter 2020 Results
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income (Loss)
Three Months Ended March 31,
2020 2019
Net income (loss) $ 34 $ (101 )
Other comprehensive income (loss), net of income taxes:
Net change in fair value of interest rate swaps, net of tax (2 )
Net change in fair value of available-for-sale debt securities, net of tax 2 2
Other comprehensive income 2
Comprehensive income (loss) 36 (101 )
Less: Comprehensive income attributable to noncontrolling interests 16 17
Comprehensive income (loss) attributable to Community Health Systems, Inc. stockholders $ 20 $ (118 )
footnotes, see pages 11, 12 and 13.
CYH Announces First Quarter 2020 Results
Last updated: Apr 28, 2020